MT Newswires2d agobullish
B. Riley Adjusts Price Target on Novavax to $16 From $18, Keeps Buy RatingNews
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
108last 24h
3128last 7d
512● bullish (7d)
311● bearish (7d)
227publishers
GuruFocus.com3d agoneutral
Novavax Inc (NVAX) (Q3 2026) Earnings Call Highlights: Sanofi Milestone Lifts Revenue Outlook ...Simply Wall St.3d agoneutral
Sanofi Stock And Why Earnings Guidance Raised Matters For Shareholders24/7 Wall St.11d agobullish
Moderna Jumps 4% Despite William Blair Downgrade on Valuation; Novavax and BioNTech Edge HigherSchaeffer's Investment Research74d agoneutral
Novavax Stock Pulls Back After Milestone Vaccine SuccessStockStory74d agoneutral
Unpacking Q2 Earnings: Novavax (NASDAQ:NVAX) In The Context Of Other Therapeutics StocksGuruFocus.com94d agoneutral
Novavax Inc (NVAX) (Q2 2026) Earnings Call Highlights: Matrix-M Momentum Drives Revenue ...Stocktwits97d agoneutral
NVAX Stock Rises Ahead Of Q2 Earnings As Focus Shifts To Licensing DealsStockStory145d agoneutral
A Look Back at Therapeutics Stocks’ Q1 Earnings: Novavax (NASDAQ:NVAX) Vs The Rest Of The Pack